Arrowhead Research Corporation (ARWR) Subsidiary Calando Pharmaceuticals, Inc. Expands Board of Directors
11/4/2009 9:15:05 AM
More...
|
Arrowhead Research Corporation (ARWR) CEO Provides Update on Company Strategy and Operations
11/3/2009 9:16:41 AM
More...
|
Cerulean Pharma Inc. Announces License Agreement with Calando Pharmaceuticals, Inc., a Subsidiary of Arrowhead Research Corporation (ARWR)
6/23/2009 3:43:33 PM
More...
|
Arrowhead Research Corporation (ARWR) CEO Comments on Recent Nasdaq Letter
2/18/2009 10:37:17 AM
More...
|
Arrowhead Research Corporation (ARWR) Reports Fourth Quarter and Full Year 2008 Financial Results
12/16/2008 8:34:56 AM
More...
|
Arrowhead Research Corporation (ARWR) CEO Provides Update on Tego Biosciences Corporation
11/19/2008 8:39:57 AM
More...
|
Arrowhead Research Corporation (ARWR) CEO Provides Update on Nanotope, Inc.
11/12/2008 10:02:13 AM
More...
|
Calando Pharmaceuticals, Inc. to Present at 19th Annual Oppenheimer Healthcare Conference on November 4, 2008
11/3/2008 10:32:02 AM
More...
|
Arrowhead Research Corporation (ARWR) CEO Provides Update on Wholly Owned Subsidiary Agonn Systems, Inc.
10/28/2008 11:42:12 AM
More...
|
Calando Pharmaceuticals, Inc. Announces Completion of IT-101 Phase 1 Clinical Study
10/23/2008 9:57:08 AM
More...
|
|